Inhibition of recovery by actinomycin D from bleomycin-induced potentially lethal damage in a B-lymphoma cell line.
D000971:Antineoplastic Combined Chemotherapy Protocols; D001761:Bleomycin / Q000494:pharmacology*; D002460:Cell Line; D003609:Dactinomycin / Q000494:pharmacology*; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy / Q000473:pathology*
D001761:Bleomycin; D003609:Dactinomycin